A detailed history of Black Rock Inc. transactions in Seer, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,648,633 shares of SEER stock, worth $9.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,648,633
Previous 5,791,042 2.46%
Holding current value
$9.6 Million
Previous $11.2 Million 4.47%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$1.54 - $2.09 $219,309 - $297,634
-142,409 Reduced 2.46%
5,648,633 $10.7 Million
Q4 2023

Feb 13, 2024

BUY
$1.47 - $2.22 $77,948 - $117,717
53,026 Added 0.92%
5,791,042 $11.2 Million
Q3 2023

Nov 13, 2023

BUY
$2.18 - $5.52 $1 Million - $2.54 Million
460,299 Added 8.72%
5,738,016 $12.7 Million
Q2 2023

Aug 11, 2023

BUY
$3.16 - $4.96 $1.19 Million - $1.86 Million
375,715 Added 7.66%
5,277,717 $22.5 Million
Q1 2023

May 12, 2023

BUY
$3.6 - $5.88 $2.73 Million - $4.46 Million
758,752 Added 18.31%
4,902,002 $18.9 Million
Q4 2022

Feb 13, 2023

BUY
$5.03 - $8.58 $1.5 Million - $2.55 Million
297,322 Added 7.73%
4,143,250 $24 Million
Q3 2022

Nov 14, 2022

BUY
$7.7 - $13.31 $185,392 - $320,464
24,077 Added 0.63%
3,845,928 $29.8 Million
Q2 2022

Aug 12, 2022

BUY
$6.72 - $16.07 $3.73 Million - $8.93 Million
555,676 Added 17.01%
3,821,851 $34.2 Million
Q1 2022

May 12, 2022

SELL
$11.88 - $23.4 $344,543 - $678,646
-29,002 Reduced 0.88%
3,266,175 $49.8 Million
Q4 2021

Feb 10, 2022

SELL
$21.08 - $38.51 $16.5 Million - $30.2 Million
-784,743 Reduced 19.23%
3,295,177 $75.2 Million
Q3 2021

Nov 09, 2021

BUY
$27.67 - $45.04 $41.6 Million - $67.7 Million
1,502,471 Added 58.29%
4,079,920 $141 Million
Q2 2021

Aug 11, 2021

BUY
$28.75 - $56.92 $74.1 Million - $147 Million
2,577,449 New
2,577,449 $84.5 Million

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $99.6M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.